Clinical Guides
Bipolar Disorder
An India-adapted guide to recognising bipolar-spectrum illness, assessing mania and depression safely, and coordinating specialist-led long-term care.
MedNext Academy | 13 min read
Bipolar Disorder
An India-adapted guide to recognising bipolar-spectrum illness, assessing mania and depression safely, and coordinating specialist-led long-term care.
Summary
Bipolar disorder is an episodic mood disorder in which periods of depression occur with mania or hypomania. Mania involves a distinct period of elevated, expansive or irritable mood with increased energy or activity and marked change from usual functioning; it can include reduced need for sleep, rapid speech, racing thoughts, grandiosity, disinhibition, excessive spending, sexual risk-taking, psychosis or severe agitation. Hypomania is less severe but remains clinically important. Bipolar depression can look like unipolar depression, and a history of mania or hypomania is often missed unless clinicians ask directly about earlier episodes and obtain collateral information.
The diagnosis is longitudinal. A single high-energy day, ordinary grief, personality style, stimulant use or medication activation is not enough. Assess episode duration, severity, impairment, psychosis, sleep, substances, medical causes, family history, prior treatments and pattern between episodes. Both mania and depression can carry high risk: suicide, self-neglect, unsafe driving, exploitation, violence, financial harm, relationship loss and loss of capacity. The immediate priority is safety and medical assessment, not persuading an acutely unwell person to agree with a label.
Bipolar disorder is treatable, and recovery plans should include medication, psychological care, sleep and routine protection, substance-use care, physical-health monitoring, family education if agreed, crisis planning and meaningful social rehabilitation. Acute mania, severe bipolar depression, psychosis, suicidal intent, inability to care for basic needs or major behavioural disinhibition requires urgent specialist assessment. This educational guide does not provide a personal medicine regimen.
How Common Is It?
Bipolar disorder occurs across cultures and includes bipolar I, bipolar II, mixed affective states and rapid cycling patterns. Comparisons of prevalence are difficult because studies use different diagnostic interviews, timeframes, thresholds for hypomania and samples. WHO's 2023 mhGAP guideline treats psychosis and bipolar disorders as priority conditions for health-system capacity building in low- and middle-income countries, but it does not make one global percentage an India-specific estimate. A national or regional estimate should be cited only from a verified comparable Indian study.
The disorder commonly first comes to clinical attention in adolescence or adulthood, but this is variable. Depressive episodes often precede a recognised manic or hypomanic episode, leading to initial treatment as unipolar depression. This is why a depression history should include periods of overactivity, reduced need for sleep, disinhibited behaviour, unusually high confidence, impulsive spending and collateral observations. Episode-free intervals can be long, yet functional, cognitive, occupational, relationship and financial consequences may persist.
Burden is not confined to acute symptoms. Cardiometabolic disease, tobacco use, alcohol and drug use, disrupted sleep, medication adverse effects, stigma and unstable work or housing can undermine recovery. In India, distance from psychiatry, cost of monitoring, inconsistent medicine supply and family distress can complicate continuity. A person who appears well today may still need relapse prevention, physical-health review and an advance crisis plan. Numbers describe population burden; they must not determine whether an individual receives careful assessment.
Risk Factors
A family history of bipolar disorder or severe mood illness increases vulnerability but does not determine a person's future. Previous manic, hypomanic, mixed, psychotic or depressive episodes are the strongest practical predictors of recurrence. Sleep loss, major life stress, bereavement, childbirth, shift work, travel across time zones, substances, stopping medication, antidepressant exposure, physical illness and psychosocial adversity can precede relapse in some people. A trigger is not a moral failing, and each patient needs a personalised pattern rather than a generic warning list.
Ask specifically about suicide and self-harm, unsafe driving, disinhibited spending or sexual behaviour, aggression, exploitation, violence, substance use, access to money or weapons, caregiving responsibilities and recent legal or occupational crises. Depression can carry concealed suicidal intent; mania can impair judgement and generate risks that the person does not recognise. Pregnancy, postpartum status and reproductive plans deserve proactive specialist review because relapse and medication decisions require careful balancing. Women and men may both face valproate-related reproductive safety issues; current Indian product information and specialist advice are essential.
Relapse risk rises when monitoring is impossible, medicines are unaffordable, adverse effects are ignored or the plan depends entirely on an exhausted family. Diabetes, obesity, hypertension, thyroid or renal disease, epilepsy, liver disease and interacting medicines affect choice and monitoring. The Indian MoHFW MNS guideline includes bipolar disorder among severe mental disorders, supporting coordinated pathways rather than a fragmented series of emergency visits. Identify protective factors too: prior effective treatment, insight after recovery, trusted support, stable routine and a written crisis plan.
Diagnosis
Diagnosis requires a detailed longitudinal psychiatric assessment, usually with specialist involvement. current guidelines, a United Kingdom comparator, advises asking adults presenting with depression about previous overactivity or disinhibited behaviour and considering specialist assessment when it lasted four days or more. That threshold is not a substitute for clinical judgement or an Indian diagnostic rule, but it illustrates why direct questions about past activation matter. Questionnaires alone should not identify bipolar disorder.
History
Describe current and prior episodes: mood, energy, sleep, speech, thoughts, activity, grandiosity, irritability, psychosis, risk-taking, impulsive spending, sexual behaviour, appetite, concentration and function. Establish duration, episodicity, recovery between episodes, admissions, self-harm, suicide attempts, violence, legal or financial consequences and treatments. Ask about antidepressant-induced activation, family history, substances, trauma, medical illness, menstrual or reproductive context, pregnancy and postpartum period. Obtain collateral history with consent where possible, especially when insight is reduced. Assess direct risk to self, others and dependants.
Examination
Complete a mental-state examination, including behaviour, speech pressure, psychomotor activity, mood, affect, thought form, thought content, perception, cognition, insight, capacity and risk. Check vital signs, weight, hydration, nutritional state, intoxication or withdrawal, neurological signs and evidence of delirium. Physical examination is guided by the presentation and will inform medicine safety.
Investigations
No blood test diagnoses bipolar disorder. Request pregnancy testing, toxicology, full blood count, glucose, renal, liver, thyroid, infection or other studies only when history, examination, medication or acute presentation makes them relevant. Before medication, record baseline physical measures and the tests required by the proposed agent. Seizure, focal deficit, fluctuating consciousness, fever or abrupt cognitive change needs medical assessment rather than routine mood-disorder follow-up.
Differential Diagnosis
Unipolar depression is a common and consequential differential because antidepressant-only treatment may be inappropriate when a bipolar pattern is present. Ask about past elevated or irritable mood, reduced need for sleep, overactivity, impulsivity and episodes that others recognised as a marked change. Psychotic depression, schizophrenia-spectrum illness and schizoaffective presentations require a careful timeline of mood and psychotic symptoms. Mania with psychosis can be mistaken for schizophrenia if episodic mood change, sleep and activity are not elicited.
Substance or medication-induced states are important: stimulants, cocaine, cannabis, alcohol withdrawal, corticosteroids and some prescribed medicines can cause activation, mood change or psychosis. They may coexist with bipolar disorder. Hyperthyroidism, neurological disease, infection, delirium, head injury, seizures and metabolic disturbance can also produce behavioural change. Acute fluctuation in attention or consciousness points away from a primary mood episode and toward a medical emergency.
ADHD, personality disorder, trauma-related symptoms, anxiety, obsessive-compulsive disorder and normal temperament can be confused with hypomania, but they generally lack the characteristic episodic sustained change in mood and energy with clear functional consequences. Bereavement and situational stress may precipitate depression without explaining repeated mania. The correct response to uncertainty is structured follow-up, collateral information and specialist review, not a premature label. Reassess the diagnosis when the course, treatment response or new medical information contradicts the initial formulation.
Management
Care combines acute stabilisation with relapse prevention and recovery support. During mania or severe depression, establish immediate safety, assess capacity, reduce environmental stimulation, address sleep, food, hydration and physical illness, and organise urgent specialist care. A collaborative written plan should record early warning signs, previous response, adverse effects, triggers, preferred contacts, supports, finances, dependants, crisis options and physical-health monitoring. If acute illness limits decision-making, continue to use the least restrictive safe approach and revisit choices as capacity returns.
Psychological work is not limited to acute symptom control. Psychoeducation, routine and sleep protection, family-focused intervention with consent, cognitive or interpersonal approaches adapted for bipolar disorder, substance-use treatment, supported work or study and social support can help prevent relapse and reduce disability. current guidelines describes psychological interventions and carer support, but its detailed recommendations are UK guidance and must be adapted to Indian service capacity. No family member should be made solely responsible for detecting or controlling mania.
Medicine treatment is specialist-led when new diagnosis, mania, severe depression, psychosis, pregnancy, recurrent relapse or complex comorbidity is present. Monitor response, adverse effects, adherence, metabolic health, renal and thyroid function where relevant and interactions. Do not advise patients to discontinue a medicine suddenly because they feel well. Review how a plan will work in real life: sleep, transport, follow-up, laboratory access, cost and medicine supply. Recovery includes restoring choice, relationships and meaningful roles, not merely avoiding hospital admission.
Prescribing Information
Medication selection, titration and discontinuation for bipolar disorder require a clinician with the necessary expertise and monitoring arrangements. Before starting or changing treatment, document the target phase, urgency, previous benefit and adverse effects, current medicines and substances, reproductive plans, pregnancy possibility, breastfeeding, renal, thyroid, liver, cardiac and metabolic history, capacity and informed preferences. current guidelines is a useful international comparator: it advises that lithium should not be newly started in primary care except under shared care, and that valproate should not be newly started in primary care. Indian prescribers must follow current Indian law, CDSCO product information and specialist standards rather than import a UK regimen.
Lithium requires reliable supply and renal, thyroid, calcium and serum-level monitoring; dehydration, acute illness, interacting medicines and abrupt cessation can make it hazardous. Antipsychotics require an individual trial with monitoring for weight, blood pressure, glucose or HbA1c, lipids, movement effects, sedation, prolactin-related effects and cardiovascular risk. Valproate has major reproductive risks and should never be treated as a casual default; use requires current specialist and product-specific safeguards. Carbamazepine and other medicines also have interaction, blood, hepatic and reproductive considerations.
Do not prescribe an antidepressant alone when bipolar disorder is suspected without specialist input. New agitation, reduced need for sleep, grandiosity, marked behavioural change, psychosis, suicidal deterioration, severe rash, fever with rigidity, syncope or neurological symptoms requires urgent review. Record the medicine, rationale, monitoring schedule, target symptoms, adverse-effect plan, crisis contact and who will obtain tests. Medicines are one part of a long-term plan, not a substitute for safety, psychotherapy and social support.
When to Refer
Urgently refer for specialist mental-health and medical assessment if mania, psychosis, severe bipolar depression, suicidal intent, serious self-harm, aggression, dangerous disinhibition, inability to care for basic needs, severe self-neglect, delirium features, severe substance intoxication or withdrawal, pregnancy-related crisis or rapid deterioration is suspected. Protect dependants and financial safety where possible, but do not attempt to manage a dangerous episode with family persuasion alone. Give a concise handover covering onset, sleep, mood, activity, risks, substances, medicines, medical signs, supports and capacity concerns.
Prompt specialist referral is needed for a first suspected bipolar episode, depressive presentations with a history suggestive of hypomania or mania, recurrent relapse, poor response, intolerable adverse effects, complex physical illness, substance dependence, pregnancy or postpartum planning, uncertainty about diagnosis, a person considering stopping maintenance treatment, or inability to obtain necessary monitoring. Medical or neurological referral is needed for thyroid symptoms, fever, seizures, focal signs, severe headache, fluctuating consciousness or a late atypical onset.
Referral must have ownership. Confirm the service, urgency, transport, medicine continuity, follow-up and emergency route. In a setting with limited psychiatry, a trained primary-care or district team may support an existing specialist care plan, monitor physical health and provide practical continuity; it should escalate when safety or diagnostic complexity exceeds scope. Any involuntary intervention must follow current applicable law, capacity safeguards and a least restrictive safe approach.
Red Flags
Manic red flags include no sleep or dramatically reduced need for sleep with rising energy, severe agitation, rapidly pressured speech, grandiosity, psychosis, escalating spending or sexual risk, reckless driving, aggression, refusal of food or fluids, disappearance from home, inability to protect oneself from exploitation or a sudden collapse of judgement. Depressive red flags include suicidal plan or intent, psychotic guilt or nihilism, refusal of essentials, profound self-neglect and inability to guarantee safety. Mixed states can combine agitation, insomnia, despair and impulsivity and may carry particularly high risk.
Medical red flags include fluctuating consciousness, fever, seizure, new focal deficit, severe headache, head injury, intoxication, withdrawal, severe dehydration, syncope or abnormal vital signs. These are not automatically “part of mania”. Fever, rigidity, autonomic instability and altered sensorium after an antipsychotic may represent a life-threatening adverse reaction and needs emergency medical care. Symptoms of lithium toxicity or an acute medicine interaction should be assessed urgently according to the product and local emergency protocol.
Safety planning must name warning signs, safe contacts, emergency services, a plan for money, transport and dependants, and how to maintain medicine and follow-up. An advance plan is most useful when made during recovery. If a person is unable to maintain safety, do not wait for a routine appointment; arrange urgent escalation.
Indian Clinical Context
The Indian MoHFW Operational Guidelines for MNS Disorders Care lists bipolar disorder within severe mental disorders and supports stepped, integrated service delivery. It is an operational framework, not a detailed Indian pharmacotherapy protocol. Local care must identify what is actually available: psychiatric assessment, emergency transport, hospital beds, laboratory monitoring, essential medicines, pregnancy counselling, psychological interventions, social services and follow-up at district or primary-care level. If a service is absent, document the limitation and find the safest available alternative rather than promising a fictional pathway.
Families often carry much of the practical burden in India. With the patient's consent, they can help recognise early warning signs, protect sleep, attend appointments and support medicine continuity. They should not be asked to police a capable adult, absorb violence, finance unsafe spending without support or make complex prescribing decisions. Confidentiality, coercion and domestic safety need explicit assessment. Address transport, wage loss, language, digital access and cost before assuming follow-up will occur.
WHO mhGAP is relevant to capacity building in low-resource settings; current guidelines is a UK comparator updated in September 2025. Neither is an Indian formulary, legal standard or proof of nationwide service availability. Indian prescribing must use current local product information and specialist advice, particularly for reproductive safety and laboratory-dependent medicines. Accurate, non-stigmatising records and a named clinician improve continuity across public and private care.
NMC Competency Mapping
Bipolar disorder integrates NMC CBME 2024 psychiatry, medicine, pharmacology, community medicine and AETCOM learning. Use the institution's current official competency ledger for exact codes; this guide does not invent them. Learners should distinguish mania, hypomania, depression, mixed symptoms and psychosis; recognise bipolar presentations in a person labelled with depression; identify medical and substance mimics; and know that risk and function matter as much as a symptom list.
At Know How level, learners should take a longitudinal episode history, ask about sleep, activity, spending, sex, driving, substances, self-harm and dependants, perform a mental-state examination, assess capacity and risk, request targeted investigations and make a safe urgent referral. They should explain why self-directed stopping, antidepressant monotherapy in an uncertain case and unmonitored use of lithium or valproate are unsafe.
An OSCE can assess a patient with depression and missed hypomania, a collateral history, a crisis handover, a physical-monitoring plan or a discussion of reproductive safety. AETCOM performance includes respect, consent, privacy, supported decision-making and a least restrictive response. Learners should demonstrate shared planning with psychiatry, primary care and family where agreed, rather than reciting a drug list.
Key Exam Pearls for NEET PG
Bipolar disorder requires a history of mania or hypomania with depressive episodes often present but not required for bipolar I. Mania is elevated or irritable mood plus increased energy or activity with reduced need for sleep, pressured speech, racing thoughts, grandiosity, disinhibition and functional impairment; psychosis or major risk makes it an emergency. In anyone presenting with depression, ask about previous periods of overactivity and disinhibited behaviour. Questionnaires alone do not diagnose bipolar disorder.
Differentiate from unipolar depression, schizophrenia-spectrum illness, substance or medication-induced states, thyroid disease, delirium, seizure and other neurological illness. Assess suicide, self-neglect, violence, driving, money, sex, substances, capacity, dependants and pregnancy status. Fluctuating consciousness, fever, seizure or focal deficit needs urgent medical work-up.
Treatment combines specialist-led medicine, psychological and social interventions, sleep and routine protection, substance care, physical-health monitoring and relapse planning. Lithium needs dependable monitoring; antipsychotics need metabolic and neurological monitoring; valproate requires major reproductive-safety precautions. Do not start or stop complex treatment casually, and do not use antidepressant monotherapy reflexively when bipolar disorder is possible. Refer mania, psychosis, severe depression, high risk, first episode, pregnancy-related cases and diagnostic uncertainty urgently.
Frequently Asked Questions
Can bipolar disorder be diagnosed from a period of feeling unusually happy?
No. Diagnosis depends on a distinct, sustained change in mood and energy or activity, associated symptoms, severity, functional effect, course over time, collateral information and exclusion of substances or medical causes. Ordinary happiness, a productive period, grief-related distress or chronic impulsivity is not automatically hypomania. Conversely, irritability, sleep loss, risky behaviour and psychosis can be mania even when a person does not describe feeling happy. A trained clinician should assess the full timeline.
Why is sleep such an important issue in bipolar disorder?
Sleep disruption can be an early warning sign, a consequence of an episode and a possible trigger for relapse in some people. Reduced need for sleep with increased energy is particularly concerning for mania, unlike simple insomnia with exhaustion. A personalised plan can protect routine, identify changes early and state whom to contact. Sleep advice alone is not adequate for escalating mania, severe depression, psychosis or suicidality; these require urgent professional assessment.
Can a person with bipolar disorder take an antidepressant?
Sometimes, but the decision is individual and usually needs specialist oversight. Antidepressants can be relevant in selected bipolar depressive presentations but may be problematic if they precipitate activation, hypomania or mania, particularly when used without appropriate mood-stabilising treatment. The clinician must review prior episodes, current phase, medicines, pregnancy possibility, interactions, response and monitoring. Do not start, stop or share a psychiatric medicine based on an educational page.
What should relatives do if someone is becoming manic?
Prioritise safety and rapid assessment. Use calm communication, reduce stimulation, avoid arguing about grandiose or paranoid beliefs, and seek urgent emergency help for psychosis, danger, no sleep with escalating activity, severe agitation, unsafe driving, spending, violence or inability to care for essentials. Do not physically restrain or secretly medicate the person. Share onset, sleep, medicines, substances, previous episodes, medical symptoms and concerns about dependants with professionals, while respecting confidentiality as far as safety allows.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic